FEDERATED HERMES, INC. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$158,308,342
-19.7%
3,442,234
+0.4%
0.42%
-13.7%
Q2 2023$197,060,608
+55.2%
3,428,930
+1.2%
0.49%
+52.8%
Q1 2023$126,997,988
+38.0%
3,386,613
+3.1%
0.32%
+26.0%
Q4 2022$92,023,760
+0.3%
3,284,217
+0.6%
0.25%
-5.6%
Q3 2022$91,751,000
-19.7%
3,265,179
-0.5%
0.27%
-13.5%
Q2 2022$114,214,000
-8.8%
3,282,967
-5.9%
0.31%
+9.9%
Q1 2022$125,199,000
+55.2%
3,487,430
+0.7%
0.28%
+88.7%
Q4 2021$80,684,000
+22.5%
3,464,335
-0.0%
0.15%
+20.0%
Q3 2021$65,871,000
-2.2%
3,465,025
+3.7%
0.12%
-0.8%
Q2 2021$67,364,000
+6.8%
3,341,501
-2.9%
0.13%
+3.3%
Q1 2021$63,046,000
-2.8%
3,441,367
+6.7%
0.12%
-8.3%
Q4 2020$64,873,000
+26.3%
3,225,883
+17.7%
0.13%
+10.8%
Q3 2020$51,381,000
-12.0%
2,740,358
+5.4%
0.12%
-17.2%
Q2 2020$58,398,000
+51.3%
2,600,107
-0.0%
0.14%
+28.3%
Q1 2020$38,586,000
+14.4%
2,600,120
+48.8%
0.11%
+50.7%
Q4 2019$33,717,000
-2.7%
1,747,907
-0.0%
0.08%
-11.8%
Q3 2019$34,661,000
+0.9%
1,747,921
+7.4%
0.08%
+2.4%
Q2 2019$34,365,000
+14.2%
1,627,903
+10.5%
0.08%
+12.2%
Q1 2019$30,092,000
+11.6%
1,472,931
+8.7%
0.07%0.0%
Q4 2018$26,973,000
+9.8%
1,355,451
+6.2%
0.07%
+29.8%
Q3 2018$24,560,000
+26.1%
1,276,508
-0.0%
0.06%0.0%
Q2 2018$19,480,000
-1.0%
1,276,552
+21.6%
0.06%0.0%
Q1 2018$19,676,000
-2.5%
1,049,410
+0.0%
0.06%0.0%
Q4 2017$20,190,000
+7.7%
1,049,395
-0.0%
0.06%
+5.6%
Q3 2017$18,753,000
+0.5%
1,049,402
+0.4%
0.05%0.0%
Q2 2017$18,667,000
+23.2%
1,045,188
+0.0%
0.05%
+25.6%
Q1 2017$15,155,000
-38.8%
1,045,170
-22.3%
0.04%
-41.9%
Q4 2016$24,769,000
-12.1%
1,344,684
-9.4%
0.07%
-8.6%
Q3 2016$28,163,000
+17.7%
1,484,6170.0%0.08%
+15.7%
Q2 2016$23,932,000
+34.3%
1,484,6170.0%0.07%
+27.3%
Q1 2016$17,815,000
-15.7%
1,484,6170.0%0.06%
-17.9%
Q4 2015$21,126,000
+21.9%
1,484,617
+0.2%
0.07%
+19.6%
Q3 2015$17,330,000
-33.4%
1,482,387
+0.1%
0.06%
-28.2%
Q2 2015$26,022,000
+17.0%
1,480,178
-0.4%
0.08%
+14.7%
Q1 2015$22,233,000
+1169.7%
1,486,153
+885.8%
0.07%
+1260.0%
Q4 2014$1,751,000
-73.8%
150,760
-73.7%
0.01%
-77.3%
Q3 2014$6,685,000573,8000.02%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2020
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders